About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials in Phoenix | 142 Studies

Clinical Trials Multiple SclerosisPhoenix

Multiple Sclerosis Clinical Trials in Phoenix

Find 142 clinical trials for multiple sclerosis near Phoenix, Arizona. Connect with research centers in your area.

All Multiple Sclerosis trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 142 trials

CompletedStudy of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)The purpose of this study is to determine whether ozanimod is effective in the treatment of relapsing multiple sclerosis (RMS).NCT02294058·Phoenix, Arizona and 223 others

Multiple Sclerosis Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

Active not recruitingA Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)This is a randomized, double-blind, controlled, parallel group, multicenter study to evaluate efficacy, safety and PK of a higher dose of ocrelizumab per intravenous (IV) infusion…NCT04544436·Cullman, Alabama and 119 others

WithdrawnVALIDATE: Factor VIII Trending for MS RelapseMultiple sclerosis (MS) patients hospitalized with an acute motor or visual relapse will be consented. Factor VIII-related labs will be systematically drawn for six months.NCT04082468·Phoenix, Arizona

CompletedOpen-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 TrialThe purpose of this study is to evaluate the safety, tolerability and activity of Fampridine-SR when administered for up to 36 additional months, or until it becomes commercially…NCT00648908·Phoenix, Arizona and 31 others

Active not recruitingStudy to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple SclerosisMulti-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 versus Placebo in Adults with Relapsing Multiple Sclerosis…NCT05134441·Phoenix, Arizona and 90 others

CompletedSafety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS)Determination the efficacy of daily oral treatment with laquinimod 0.6 mg capsules as compared to placebo in subjects with Relapsing Remitting Multiple Sclerosis (RRMS).NCT00509145·Phoenix, Arizona and 143 others

CompletedTele-Exercise and Multiple SclerosisThe purpose of this study is to compare the effects of two delivery models of an evidence-based complementary alternative medicine (CAM) program that combines neurorehabilitative…NCT03117881·Athens, Alabama and 39 others

CompletedSafety and Efficacy Study of Oral Fampridine-SR in Patients With Multiple SclerosisMultiple Sclerosis (MS) is a disorder of the body's immune system that affects the Central Nervous System (CNS).NCT00053417·Phoenix, Arizona and 24 others

CompletedStudy to Evaluate the Safety and Efficacy of PIPE-307 in Subjects With Relapsing-Remitting Multiple SclerosisThis is a randomized, double-blind study of PIPE-307 or placebo in subjects with relapsing-remitting multiple sclerosis.NCT06083753·Phoenix, Arizona and 20 others

CompletedDetermine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN TherapyAn observational study to determine the impact of multiple neutralizing antibody (NAb) tests on treatment patterns compared to the usual care of MS patients receiving high-dose…NCT00336557·Phoenix, Arizona and 48 others

CompletedA Study of C105 on Cognitive Dysfunction in Persons With Multiple SclerosisThe purpose of this study is to determine the safety and efficacy of C105 in treating the cognitive deficits that can occur due to multiple sclerosis.NCT00529581·Phoenix, Arizona and 29 others

CompletedBG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS)The primary objective of this study is to evaluate the long-term safety profile of BG00012 (dimethyl fumarate).NCT00835770·Birmingham, Alabama and 245 others

CompletedPhase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409Primary Objective: To evaluate long-term safety of alemtuzumab. Secondary Objectives: * To evaluate long term efficacy of alemtuzumab.NCT02255656·Cullman, Alabama and 130 others

Active not recruitingA Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) ElevationThis study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofatumumab versus staying on their…NCT05090371·Birmingham, Alabama and 42 others

CompletedAutologous T Cell Vaccine (TCV) for Multiple SclerosisThis is a 1 year study to evaluate the efficacy, safety, and tolerability of Tovaxin T cell therapy in subjects with a clinically isolated syndrome (CIS) and relapse-remitting…NCT00245622·Cullman, Alabama and 32 others

CompletedTraditional Versus Early Aggressive Therapy for Multiple Sclerosis TrialFDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) target the relapsing phase of MS but have minimal impact once the progressive phase has begun.NCT03500328·Birmingham, Alabama and 46 others

Active not recruitingA Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)This study aims to examine the efficacy and safety of obexelimab in participants with relapsing multiple sclerosisNCT06564311·Cullman, Alabama and 46 others

CompletedA Multicenter Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With OfatumumabThis is a single arm, pilot multicenter prospective study in up to 22 participants with relapsing multiple sclerosis.NCT04847596·Phoenix, Arizona and 4 others

TerminatedStudy Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063)This is a multicenter, longitudinal, single-arm, open-label study to describe the change from baseline in cognitive processing speed, measured by the SDMT, in subjects with RMS…NCT04140305·Birmingham, Alabama and 60 others

CompletedBRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)The study aims to compare the effect of daily oral treatment of laquinimod capsules 0.6 milligrams (mg) with the effect of placebo capsules (capsules that contain no active…NCT00605215·Birmingham, Alabama and 169 others

Page 1 of 8Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia